Docket #: S97-184
Monoclonal Antibody to Human CD81, 5A6
5A6 is monoclonal antibody (mAbs) which recognizes human CD81. It was identified by its ability to induce a reversible antiproliferative effect on a human lymphoma B cell line. This mAbs is capable of inducing signal signal transduction and cell adhesion. It is shown to bind to the large extracellular loop (EC2) of human CD81.
Applications
- Flow cytometric studies
- Immunoprecipitations
- Western blots
Advantages
- Most potent inducer of biological responses (i.e. antiproliferative effect, induction of homotypic adhesion, and inhibition of motility in lymphoid cells) compared to currently available CD81 mAbs.
- Excellent Western reagent
Publications
- "TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins." Oren R, Takahashi S, Doss C, Levy R, Levy S, Mol Cell Biol. 1990 Aug; 10(8): 4007-4015.
Similar Technologies
-
A method for developing intra-epithelial innate lymphoid cells (tissue-resident NK cells) for immunotherapy S19-363A method for developing intra-epithelial innate lymphoid cells (tissue-resident NK cells) for immunotherapy
-
Novel ENPP1 and ENPP3 Inhibitors for Cancer Immunotherapy S24-180Novel ENPP1 and ENPP3 Inhibitors for Cancer Immunotherapy
-
Lymphodepletion by Selective Apoptosis Induction in T Cells for Safe and Effective Immune Tolerance in Immunotherapy, Transplantation, and Autoimmunity S22-458Lymphodepletion by Selective Apoptosis Induction in T Cells for Safe and Effective Immune Tolerance in Immunotherapy, Transplantation, and Autoimmunity